Ultragenyx Pharmaceutical
Trade Ultragenyx Pharmaceutical 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About RARE
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.
RARE Key Statistics
Stock Snapshot
As of today, Ultragenyx Pharmaceutical(RARE) shares are valued at $24.70. The company's market cap stands at 2.38B, with a P/E ratio of -4.16.
On 2026-02-09, Ultragenyx Pharmaceutical(RARE) stock traded between a low of $23.89 and a high of $24.87. Shares are currently priced at $24.70, which is +3.4% above the low and -0.7% below the high.
Ultragenyx Pharmaceutical(RARE) shares are trading with a volume of 2.65M, against a daily average of 2.31M.
During the past year, Ultragenyx Pharmaceutical(RARE) stock moved between $18.41 at its lowest and $46.27 at its peak.
During the past year, Ultragenyx Pharmaceutical(RARE) stock moved between $18.41 at its lowest and $46.27 at its peak.
RARE News
New insider activity at Ultragenyx Pharmaceutical ( (RARE) ) has taken place on February 3, 2026. CFO Howard Horn unloaded 3,061 shares of Ultragenyx Pharmaceu...
Ultragenyx Pharmaceutical ( (RARE) ) has shared an update. On February 3, 2026, Ultragenyx Pharmaceutical reported new long-term clinical data for UX111 (rebis...
Analyst ratings
95%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.